32 related articles for article (PubMed ID: 9714468)
1. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue.
McIntosh GG; Lodge AJ; Watson P; Hall AG; Wood K; Anderson JJ; Angus B; Horne CH; Milton ID
Am J Pathol; 1999 Jan; 154(1):77-82. PubMed ID: 9916921
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia.
Boris E; Theron A; Montagnon V; Rouquier N; Almeras M; Moreaux J; Bret C
Cytometry B Clin Cytom; 2024 Jan; 106(1):45-57. PubMed ID: 38037221
[TBL] [Abstract][Full Text] [Related]
3. [Expression characteristics and clinical significance of CD109 in de novo acute myeloid leukemia].
Wang LX; Chen Y; Dong ST; Ren FG; Zhang YF; Chang JM; Tan YH; Chen XH; Wang HW; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):770-774. PubMed ID: 38049323
[No Abstract] [Full Text] [Related]
4. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.
Verbeek MWC; van der Velden VHJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732101
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy.
Buchmann I; Kull T; Glatting G; Bunjes D; Hale G; Kotzerke J; Rattat D; Dohner H; Reske SN
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):667-73. PubMed ID: 12599012
[TBL] [Abstract][Full Text] [Related]
6. The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.
Matthews DC; Appelbaum FR; Press OW; Eary JF; Bernstein ID
Cancer Treat Res; 1997; 77():121-39. PubMed ID: 9071501
[No Abstract] [Full Text] [Related]
7. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
8. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
[TBL] [Abstract][Full Text] [Related]
9. [Expression of CD66c (CEACM6) in adult acute leukemia and its significance].
Chen BG; Yan WH; Meng ZF; Guo ZM; Zhu M; Li BL
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):370-3. PubMed ID: 17147224
[TBL] [Abstract][Full Text] [Related]
10. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
11. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
[TBL] [Abstract][Full Text] [Related]
12. CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.
Boccuni P; Di Noto R; Lo Pardo C; Villa MR; Ferrara F; Rotoli B; Del Vecchio L
Tissue Antigens; 1998 Jul; 52(1):1-8. PubMed ID: 9714468
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
